semaglutide med spa houston Medical Weight Loss – Ovation Semaglutide Weight Loss in Houston

The first phase 3 retatrutide trial, TRIUMPH-4, top-line data announced today Retatrutide, a triple GLP-1,GIP, glucagon agonist studied in patients with obesity and osteoarthritis 28.7% weight loss at 68 weeks Reduced key cardiometabolic risk markers non-HDL cholesterol, triglycerides, and hsCRP Highest dose lowered systolic BP by 14 mmHg Reduced WOMAC pain scores by up to an average of 4.5 points (75.8%) and significantly improved measures of physical function GI side effects most common adverse event We now await 7 additional phase 3 trials in other obesity related comorbidities

Understanding these interactions requires individualized provider guidance based on your complete medical history and current medication list

Understanding their distinct mechanisms helps clarify which medication strategy may support your personalized weight management plan

Experience expert guidance, personalized meal plans, body composition tracking, and full support at Euphoria Medspa your trusted provider for effective, safe weight transformation.

Discover effective weight loss with compounded GLP-1 medications at Roxborough Clinic in Silver Spring, MD